About Affymetrix (NASDAQ:AFFX)
Affymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.
Industry, Sector and Symbol
Sub-IndustryLife Sciences Tools & Services
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity4.84%
Return on Assets2.97%
Affymetrix (NASDAQ:AFFX) Frequently Asked Questions
What is Affymetrix's stock symbol?
Affymetrix trades on the NASDAQ under the ticker symbol "AFFX."
How were Affymetrix's earnings last quarter?
Affymetrix, Inc. (NASDAQ:AFFX) announced its quarterly earnings results on Wednesday, February, 17th. The scientific and technical instruments company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by $0.02. The scientific and technical instruments company earned $95.60 million during the quarter, compared to the consensus estimate of $93.29 million. Affymetrix had a net margin of 4.24% and a return on equity of 4.84%. During the same quarter last year, the company earned $0.09 earnings per share. View Affymetrix's Earnings History.
Who are some of Affymetrix's key competitors?
Some companies that are related to Affymetrix include NovoCure (NVCR), Mimecast (MIME), The Trade Desk (TTD), First Interstate BancSystem (FIBK), United Natural Foods (UNFI), Renasant (RNST), Cogent Communications (CCOI), Financial Engines (FNGN), BlackLine (BL), Bloomin' Brands (BLMN), The Medicines (MDCO), Allscripts (MDRX), Exponent (EXPO), Builders FirstSource (BLDR), The Advisory Board (ABCO), Global Blood Therapeutics (GBT), SodaStream (SODA) and Portola Pharmaceuticals (PTLA).
Has Affymetrix been receiving favorable news coverage?
News stories about AFFX stock have trended positive this week, Accern Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Affymetrix earned a media sentiment score of 0.29 on Accern's scale. They also assigned news articles about the scientific and technical instruments company an impact score of 46.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
How do I buy shares of Affymetrix?
Shares of AFFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Affymetrix's stock price today?
One share of AFFX stock can currently be purchased for approximately $14.01.
How big of a company is Affymetrix?
Affymetrix has a market capitalization of $1.13 billion.
How can I contact Affymetrix?
Affymetrix's mailing address is 3420 Central Expy, SANTA CLARA, CA 95051-0703, United States. The scientific and technical instruments company can be reached via phone at +1-408-7315000.
MarketBeat Community Rating for Affymetrix (AFFX)MarketBeat's community ratings are surveys of what our community members think about Affymetrix and other stocks. Vote "Outperform" if you believe AFFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Affymetrix (NASDAQ:AFFX) Analyst Ratings History
(Data available from 4/21/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Affymetrix (NASDAQ:AFFX) Earnings History and Estimates Chart
Affymetrix (NASDAQ AFFX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/17/2016||Q415||$0.11||$0.09||$93.29 million||$95.60 million||View||N/A|
|10/28/2015||Q315||$0.08||$0.10||$88.04 million||$86.50 million||View||Listen|
|7/29/2015||Q215||$0.07||$0.12||$88.61 million||$89.00 million||View||Listen|
|4/29/2015||Q115||$0.04||$0.10||$87.30 million||$88.70 million||View||Listen|
|2/4/2015||Q414||$0.07||$0.09||$91.80 million||$93.50 million||View||Listen|
|10/30/2014||Q314||$0.04||$0.08||$84.40 million||$87.10 million||View||Listen|
|7/31/2014||Q214||$0.03||$0.07||$83.30 million||$85.40 million||View||Listen|
|5/1/2014||Q114||$0.02||$0.03||$81.10 million||$83.00 million||View||Listen|
|2/5/2014||Q413||$0.07||$0.02||$89.98 million||$92.60 million||View||Listen|
|10/30/2013||Q3 2013||$0.02||$0.05||$78.85 million||$80.35 million||View||N/A|
|7/31/2013||Q2 2013||($0.01)||$0.04||$78.53 million||$79.46 million||View||Listen|
|4/30/2013||Q1 2013||($0.02)||($0.01)||$78.04 million||$77.90 million||View||Listen|
|1/31/2013||Q4 2012||($0.03)||($0.02)||$84.06 million||$84.40 million||View||Listen|
|11/5/2012||Q312||($0.03)||($0.03)||$84.56 million||$79.60 million||View||N/A|
Affymetrix (NASDAQ:AFFX) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Affymetrix (NASDAQ AFFX) Insider Trading and Institutional Ownership History
Affymetrix (NASDAQ AFFX) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|12/15/2015||Robert H Trice||Director||Sell||2,500||$9.40||$23,500.00||47,278|| |
|11/17/2015||Robert H Trice||Director||Sell||2,500||$9.00||$22,500.00||47,278|| |
|10/15/2015||Robert H Trice||Director||Sell||2,500||$9.00||$22,500.00||47,278|| |
|7/20/2015||Frank Witney||CEO||Sell||37,991||$11.20||$425,499.20|| |
|7/10/2015||Frank Witney||CEO||Sell||62,756||$11.00||$690,316.00|| |
|6/26/2015||Frank Witney||CEO||Sell||75,000||$11.22||$841,500.00|| |
|6/22/2015||David A Weber||EVP||Sell||33,879||$12.00||$406,548.00|| |
|6/19/2015||David A Weber||EVP||Sell||14,760||$12.00||$177,120.00|| |
|6/4/2015||Frank Witney||CEO||Sell||75,000||$11.78||$883,500.00|| |
|2/17/2015||Gavin Wood||CFO||Sell||1,300||$11.40||$14,820.00|| |
|1/20/2015||Gavin Wood||CFO||Sell||22,500||$11.77||$264,825.00|| |
|1/12/2015||Gavin Wood||CFO||Sell||10,200||$10.77||$109,854.00|| |
|12/29/2014||Gavin Wood||CFO||Sell||18,734||$10.20||$191,086.80|| |
|11/19/2013||Robert Trice||Director||Sell||6,205||$7.98||$49,515.90||53,199|| |
|8/21/2012||Timothy C Barabe||CFO||Buy||10,000||$3.75||$37,500.00|| |
|8/17/2012||Timothy C Barabe||CFO||Buy||5,550||$3.99||$22,144.50|| |
|8/13/2012||Timothy C Barabe||CFO||Buy||4,450||$3.99||$17,755.50|| |
Affymetrix (NASDAQ AFFX) News Headlines
Affymetrix (NASDAQ:AFFX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Affymetrix (NASDAQ:AFFX) Income Statement, Balance Sheet and Cash Flow Statement
Affymetrix (NASDAQ AFFX) Stock Chart for Saturday, April, 21, 2018